Baseline PA/BSA ratio in patients undergoing transcatheter aortic valve replacement – A novel CT-based marker for the prediction of pulmonary hypertension and outcome. (1st February 2022)

• Record Type: Journal Article
• Authors: Sudo, Mitsumasa; Sugiura, Atsushi; Treiling, Louisa; Al-Kassou, Baravan; Shamekhi, Jasmin; Kütting, Daniel; Wilde, Nihal; Weber, Marcel; Zimmer, Sebastian; Nickenig, Georg; Sedaghat, Alexander
• Is Part Of: International journal of cardiology. Volume 348(2022)
• Page Start: 26
• Page End: 32
• Publication Date: 2022-02-01
• Subjects: Aortic stenosis -- Transcatheter aortic valve replacement -- Pulmonary artery -- Computed tomography; Cardiology -- Periodicals; Electronic journals; 616.12
• DOI: 10.1016/j.ijcard.2021.12.019
• Languages: English
• ISSNs: 0167-5273

Abstract

Abstract: Background: Pulmonary hypertension (pH) has a prognostic impact on patients undergoing transcatheter aortic valve replacement (TAVR). Pulmonary artery (PA) dilatation assessed by multidetector computed tomography (MDCT) has the potential to predict PH. The aim of the study was to evaluate the clinical parameters associated with PA dilatation and to investigate its prognostic relevance in patients undergoing TAVR. Methods: In 770 patients undergoing TAVR between February 2016 and July 2019, PA diameter was measured by MDCT before TAVR. Additionally, PA diameter divided by ascending aorta diameter or body surface area (BSA) was calculated. Results: Of all the CT-derived parameters compared with a receiver operating characteristic curve, the value for PA/BSA with a median of 1.68 (IQR 1.47, 1.91) cm/m2 showed the greatest area-under-the-curve (0.75) for predicting PH at baseline. Based on this median, patients were assigned to a small PA/BSA ( n = 386) or a large PA/BSA ( n = 384) group. Hereby, a large PA/BSA was independently associated with PH at baseline (OR:8.39 [5.36–13.14], p < 0.001) and after TAVR (OR:1.73 [1.18–2.53], p = 0.005). A large PA/BSA was associated with a significantly higher cumulative two-year all-cause mortality compared to small PA/BSA (30.0% vs. 13.7%, p < 0.001), which was supported in the multivariable model (HR:1.87; 95%CI, 1.12–3.04; p = 0.017). Conclusion: Patients with a large PA/BSA on MDCT are more likely to have PH at baseline and after TAVR. Large PA/BSA is associated with an increased risk of mortality and could provide additional information for risk stratification in patients undergoing TAVR. Highlights: The PA/BSA is better for predicting PH compared to other CT-derived parameters. PA dilatation, as assessed by a PA/BSA, is related to reduced right-heart function. The PA/BSA was associated with post-procedural PH. A large PA/BSA is associated with two-year all-cause mortality.